NCT01216033View on ClinicalTrials.gov

Exploratory Study of Breast Cancer With ABY025

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Breast Cancer
Interventions
DRUG

111-In-ABY-025

Intravenous injection of the agent

Trial Locations (1)

SE75185

Akademiska Hospital, Uppsala

Sponsors
All Listed Sponsors
collaborator

Swedish Cancer Society

OTHER

lead

Biomedical Radiation Sciences

OTHER